Strategic Analysis of Downstream Processing in Biopharmaceutical Production

1 STRATEGIC ANALYSIS OF DOWNSTREAM PROCESSING IN BIOPHARMACEUTICAL PRODUCTION

• Overview
  • Overview
• Research Scope & Methodology
  • Research Scope & Methodology
• Introduction & Background
  • Introduction & Background
• Market Dynamics
  • Market Dynamics
  • Industry Challenges
  • Key Market Trends
  • Key Technology Trends
  • Key Market Drivers
  • Key Market Restraints
• Future Technology Dynamics
  • Future Technology Dynamics
  • Key Technology Drivers
  • Key Technology Restraints
  • Biopharmaceutical Production Costs
  • Analysis of Emerging Technologies
  • Integrated Solutions
  • Major Challenges and Remedial Strategies
• Contract Manufacturing Organisations (CMOs)
  • Contract Manufacturing Organisations (CMOs)
  • Forecast Assumptions
  • CMOs in Downstream Processing
  • CMO Market Drivers
  • CMO Market Restraints
  • Key Market Engineering Measurements
  • Total Market Revenue Forecast
  • Revenue Analysis
  • Competitive Profiles
  • CMO Geographic Distribution
• Strategic Analysis & Recommendations
  • Strategic Analysis & Recommendations
  • Strategic Analysis
  • Strategic Anticipation
  • Market Maturation Process
  • Competitive Framework
  • Potential Threats
  • Meeting the Challenge
  • Meeting the Challenge - Product Pricing Strategy
  • Meeting the Challenge - Strategic Postures
• Frost & Sullivan Awards
  • Frost & Sullivan Awards
  • Frost & Sullivan Awards Description
  • Product Innovation Award
  • Technology Leadership Award
  • Customer Service Innovation Award
  • Market Leadership Award
  • Product Differentiation Innovation Award
• Decision Support Databases
  • Decision Support Databases
  • Global Pharmaceutical R&D Expenditure (1999-2006)
  • Number of Biotechnology Companies (1999 - 2006)
  • Top 10 Global Pharmaceutical Drug Sales (2003)
  • Percentage of Pharmaceutical R&D Expenditure (1999-2006)
• Frost & Sullivan
  • Healthcare Team
  • Our Capabilities